Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 10 of 10 entries
Sorted by: Best Match Show Resources per page
Immunisation financing and programme performance in the Middle East and North Africa, 2010 to 2017.

BMJ global health

Saxenian H, Sadr-Azodi N, Kaddar M, Senouci K.
PMID: 30997167
BMJ Glob Health. 2019 Mar 30;4(2):e001248. doi: 10.1136/bmjgh-2018-001248. eCollection 2019.

Immunisation is a cornerstone to primary health care and is an exceptionally good value. The 14 low-income and middle-income countries in the Middle East and North Africa region make up 88% of the region's population and 92% of its...

Cite
Saxenian H, Sadr-Azodi N, Kaddar M, et al. Immunisation financing and programme performance in the Middle East and North Africa, 2010 to 2017. BMJ Glob Health. 2019;4(2):e001248doi: 10.1136/bmjgh-2018-001248.
Saxenian, H., Sadr-Azodi, N., Kaddar, M., & Senouci, K. (2019). Immunisation financing and programme performance in the Middle East and North Africa, 2010 to 2017. BMJ global health, 4(2), e001248. https://doi.org/10.1136/bmjgh-2018-001248
Saxenian, Helen, et al. "Immunisation financing and programme performance in the Middle East and North Africa, 2010 to 2017." BMJ global health vol. 4,2 (2019): e001248. doi: https://doi.org/10.1136/bmjgh-2018-001248
Saxenian H, Sadr-Azodi N, Kaddar M, Senouci K. Immunisation financing and programme performance in the Middle East and North Africa, 2010 to 2017. BMJ Glob Health. 2019 Mar 30;4(2):e001248. doi: 10.1136/bmjgh-2018-001248. eCollection 2019. PMID: 30997167; PMCID: PMC6441300.
Copy Download .nbib Format: NLM
A tug-of-war in intraductal papillary mucinous neoplasms management: Comparison between 2017 International and 2018 European guidelines.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Crippa S, Fogliati A, Valente R, Sadr-Azodi O, Arnelo U, Capurso G, Halimi A, Partelli S, Ateeb Z, Arcidiacono PG, Lohr JM, Falconi M, Del Chiaro M.
PMID: 33846103
Dig Liver Dis. 2021 Aug;53(8):998-1003. doi: 10.1016/j.dld.2021.03.009. Epub 2021 Apr 10.

BACKGROUND: 2017 International and 2018 European guidelines are the most recent guidelines for intraductal papillary mucinous neoplasms management.AIM: to evaluate the diagnostic accuracy of these guidelines in identifying malignant IPMN.METHODS: data from resected patients with IPMN were collected in...

Cite
Crippa S, Fogliati A, Valente R, et al. A tug-of-war in intraductal papillary mucinous neoplasms management: Comparison between 2017 International and 2018 European guidelines. Dig Liver Dis. 2021;53(8):998-1003doi: 10.1016/j.dld.2021.03.009.
Crippa, S., Fogliati, A., Valente, R., Sadr-Azodi, O., Arnelo, U., Capurso, G., Halimi, A., Partelli, S., Ateeb, Z., Arcidiacono, P. G., Lohr, J. M., Falconi, M., & Del Chiaro, M. (2021). A tug-of-war in intraductal papillary mucinous neoplasms management: Comparison between 2017 International and 2018 European guidelines. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 53(8), 998-1003. https://doi.org/10.1016/j.dld.2021.03.009
Crippa, Stefano, et al. "A tug-of-war in intraductal papillary mucinous neoplasms management: Comparison between 2017 International and 2018 European guidelines." Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver vol. 53,8 (2021): 998-1003. doi: https://doi.org/10.1016/j.dld.2021.03.009
Crippa S, Fogliati A, Valente R, Sadr-Azodi O, Arnelo U, Capurso G, Halimi A, Partelli S, Ateeb Z, Arcidiacono PG, Lohr JM, Falconi M, Del Chiaro M. A tug-of-war in intraductal papillary mucinous neoplasms management: Comparison between 2017 International and 2018 European guidelines. Dig Liver Dis. 2021 Aug;53(8):998-1003. doi: 10.1016/j.dld.2021.03.009. Epub 2021 Apr 10. PMID: 33846103.
Copy Download .nbib Format: NLM
Menopausal hormone therapy and pancreatic cancer risk in women: a population-based matched cohort study.

United European gastroenterology journal

Sadr-Azodi O, Konings P, Brusselaers N.
PMID: 29238591
United European Gastroenterol J. 2017 Dec;5(8):1123-1128. doi: 10.1177/2050640617702060. Epub 2017 Apr 09.

BACKGROUND: The role of menopausal hormone therapy (MHT) in the development of pancreatic cancer is inconclusive owing to small studies and lack of proper study design.METHODS: This population-based matched cohort study included all Swedish women who used systemic MHT...

Cite
Sadr-Azodi O, Konings P, Brusselaers N. Menopausal hormone therapy and pancreatic cancer risk in women: a population-based matched cohort study. United European Gastroenterol J. 2017;5(8):1123-1128doi: 10.1177/2050640617702060.
Sadr-Azodi, O., Konings, P., & Brusselaers, N. (2017). Menopausal hormone therapy and pancreatic cancer risk in women: a population-based matched cohort study. United European gastroenterology journal, 5(8), 1123-1128. https://doi.org/10.1177/2050640617702060
Sadr-Azodi, Omid, et al. "Menopausal hormone therapy and pancreatic cancer risk in women: a population-based matched cohort study." United European gastroenterology journal vol. 5,8 (2017): 1123-1128. doi: https://doi.org/10.1177/2050640617702060
Sadr-Azodi O, Konings P, Brusselaers N. Menopausal hormone therapy and pancreatic cancer risk in women: a population-based matched cohort study. United European Gastroenterol J. 2017 Dec;5(8):1123-1128. doi: 10.1177/2050640617702060. Epub 2017 Apr 09. PMID: 29238591; PMCID: PMC5721980.
Copy Download .nbib Format: NLM
Proton pump inhibitors and survival in patients with colorectal cancer: a Swedish population-based cohort study.

British journal of cancer

Wang X, Liu Q, Halfdanarson ÓÖ, Zoega H, Sadr-Azodi O, Engstrand L, Fall K, Brusselaers N.
PMID: 34253872
Br J Cancer. 2021 Sep;125(6):893-900. doi: 10.1038/s41416-021-01480-0. Epub 2021 Jul 12.

BACKGROUND: Proton pump inhibitors (PPIs) are associated with microbiome changes of the gut, which in turn may affect the progression of colorectal cancer (CRC). This study aims to assess the associations between PPI use and all-cause and CRC-specific mortality.METHODS:...

Cite
Wang X, Liu Q, Halfdanarson ÓÖ, et al. Proton pump inhibitors and survival in patients with colorectal cancer: a Swedish population-based cohort study. Br J Cancer. 2021;125(6):893-900doi: 10.1038/s41416-021-01480-0.
Wang, X., Liu, Q., Halfdanarson, �. �. �. �., Zoega, H., Sadr-Azodi, O., Engstrand, L., Fall, K., & Brusselaers, N. (2021). Proton pump inhibitors and survival in patients with colorectal cancer: a Swedish population-based cohort study. British journal of cancer, 125(6), 893-900. https://doi.org/10.1038/s41416-021-01480-0
Wang, Xinchen, et al. "Proton pump inhibitors and survival in patients with colorectal cancer: a Swedish population-based cohort study." British journal of cancer vol. 125,6 (2021): 893-900. doi: https://doi.org/10.1038/s41416-021-01480-0
Wang X, Liu Q, Halfdanarson ÓÖ, Zoega H, Sadr-Azodi O, Engstrand L, Fall K, Brusselaers N. Proton pump inhibitors and survival in patients with colorectal cancer: a Swedish population-based cohort study. Br J Cancer. 2021 Sep;125(6):893-900. doi: 10.1038/s41416-021-01480-0. Epub 2021 Jul 12. PMID: 34253872; PMCID: PMC8438017.
Copy Download .nbib Format: NLM
Association Between Proton Pump Inhibitor Use and Biliary Tract Cancer Risk: A Swedish Population-Based Cohort Study.

Hepatology (Baltimore, Md.)

Kamal H, Sadr-Azodi O, Engstrand L, Brusselaers N.
PMID: 34018229
Hepatology. 2021 Oct;74(4):2021-2031. doi: 10.1002/hep.31914. Epub 2021 Jul 13.

BACKGROUND AND AIMS: Biliary tract cancer is a group of highly aggressive malignant disorders, yet risk factors are poorly understood. In this study, we aim to assess whether prolonged use of proton pump inhibitors (PPIs) increases the risk of...

Cite
Kamal H, Sadr-Azodi O, Engstrand L, et al. Association Between Proton Pump Inhibitor Use and Biliary Tract Cancer Risk: A Swedish Population-Based Cohort Study. Hepatology. 2021;74(4):2021-2031doi: 10.1002/hep.31914.
Kamal, H., Sadr-Azodi, O., Engstrand, L., & Brusselaers, N. (2021). Association Between Proton Pump Inhibitor Use and Biliary Tract Cancer Risk: A Swedish Population-Based Cohort Study. Hepatology (Baltimore, Md.), 74(4), 2021-2031. https://doi.org/10.1002/hep.31914
Kamal, Habiba, et al. "Association Between Proton Pump Inhibitor Use and Biliary Tract Cancer Risk: A Swedish Population-Based Cohort Study." Hepatology (Baltimore, Md.) vol. 74,4 (2021): 2021-2031. doi: https://doi.org/10.1002/hep.31914
Kamal H, Sadr-Azodi O, Engstrand L, Brusselaers N. Association Between Proton Pump Inhibitor Use and Biliary Tract Cancer Risk: A Swedish Population-Based Cohort Study. Hepatology. 2021 Oct;74(4):2021-2031. doi: 10.1002/hep.31914. Epub 2021 Jul 13. PMID: 34018229.
Copy Download .nbib Format: NLM
Cholecystectomy in Patients with Liver Cirrhosis.

Gastroenterology research and practice

Strömberg J, Hammarqvist F, Sadr-Azodi O, Sandblom G.
PMID: 26788053
Gastroenterol Res Pract. 2015;2015:783823. doi: 10.1155/2015/783823. Epub 2015 Dec 14.

Background. The aim of this population-based study was to describe characteristics of patients with liver cirrhosis undergoing cholecystectomy and evaluate the risk for perioperative and postoperative complications during the 30-day postoperative period. Method. All laparoscopic and open cholecystectomy procedures...

Cite
Strömberg J, Hammarqvist F, Sadr-Azodi O, et al. Cholecystectomy in Patients with Liver Cirrhosis. Gastroenterol Res Pract. 2015;2015:783823doi: 10.1155/2015/783823.
Strömberg, J., Hammarqvist, F., Sadr-Azodi, O., & Sandblom, G. (2015). Cholecystectomy in Patients with Liver Cirrhosis. Gastroenterology research and practice, 2015783823. https://doi.org/10.1155/2015/783823
Strömberg, Jonas, et al. "Cholecystectomy in Patients with Liver Cirrhosis." Gastroenterology research and practice vol. 2015 (2015): 783823. doi: https://doi.org/10.1155/2015/783823
Strömberg J, Hammarqvist F, Sadr-Azodi O, Sandblom G. Cholecystectomy in Patients with Liver Cirrhosis. Gastroenterol Res Pract. 2015;2015:783823. doi: 10.1155/2015/783823. Epub 2015 Dec 14. PMID: 26788053; PMCID: PMC4691627.
Copy Download .nbib Format: NLM
Association Between Proton Pump Inhibitor Use and Biliary Tract Cancer Risk: A Swedish Population-Based Cohort Study.

Hepatology (Baltimore, Md.)

Kamal H, Sadr-Azodi O, Engstrand L, Brusselaers N.
PMID: 34018229
Hepatology. 2021 Oct;74(4):2021-2031. doi: 10.1002/hep.31914. Epub 2021 Jul 13.

BACKGROUND AND AIMS: Biliary tract cancer is a group of highly aggressive malignant disorders, yet risk factors are poorly understood. In this study, we aim to assess whether prolonged use of proton pump inhibitors (PPIs) increases the risk of...

Cite
Kamal H, Sadr-Azodi O, Engstrand L, et al. Association Between Proton Pump Inhibitor Use and Biliary Tract Cancer Risk: A Swedish Population-Based Cohort Study. Hepatology. 2021;74(4):2021-2031doi: 10.1002/hep.31914.
Kamal, H., Sadr-Azodi, O., Engstrand, L., & Brusselaers, N. (2021). Association Between Proton Pump Inhibitor Use and Biliary Tract Cancer Risk: A Swedish Population-Based Cohort Study. Hepatology (Baltimore, Md.), 74(4), 2021-2031. https://doi.org/10.1002/hep.31914
Kamal, Habiba, et al. "Association Between Proton Pump Inhibitor Use and Biliary Tract Cancer Risk: A Swedish Population-Based Cohort Study." Hepatology (Baltimore, Md.) vol. 74,4 (2021): 2021-2031. doi: https://doi.org/10.1002/hep.31914
Kamal H, Sadr-Azodi O, Engstrand L, Brusselaers N. Association Between Proton Pump Inhibitor Use and Biliary Tract Cancer Risk: A Swedish Population-Based Cohort Study. Hepatology. 2021 Oct;74(4):2021-2031. doi: 10.1002/hep.31914. Epub 2021 Jul 13. PMID: 34018229.
Copy Download .nbib Format: NLM
Association Between Proton Pump Inhibitor Use and Biliary Tract Cancer Risk: A Swedish Population-Based Cohort Study.

Hepatology (Baltimore, Md.)

Kamal H, Sadr-Azodi O, Engstrand L, Brusselaers N.
PMID: 34018229
Hepatology. 2021 Oct;74(4):2021-2031. doi: 10.1002/hep.31914. Epub 2021 Jul 13.

BACKGROUND AND AIMS: Biliary tract cancer is a group of highly aggressive malignant disorders, yet risk factors are poorly understood. In this study, we aim to assess whether prolonged use of proton pump inhibitors (PPIs) increases the risk of...

Cite
Kamal H, Sadr-Azodi O, Engstrand L, et al. Association Between Proton Pump Inhibitor Use and Biliary Tract Cancer Risk: A Swedish Population-Based Cohort Study. Hepatology. 2021;74(4):2021-2031doi: 10.1002/hep.31914.
Kamal, H., Sadr-Azodi, O., Engstrand, L., & Brusselaers, N. (2021). Association Between Proton Pump Inhibitor Use and Biliary Tract Cancer Risk: A Swedish Population-Based Cohort Study. Hepatology (Baltimore, Md.), 74(4), 2021-2031. https://doi.org/10.1002/hep.31914
Kamal, Habiba, et al. "Association Between Proton Pump Inhibitor Use and Biliary Tract Cancer Risk: A Swedish Population-Based Cohort Study." Hepatology (Baltimore, Md.) vol. 74,4 (2021): 2021-2031. doi: https://doi.org/10.1002/hep.31914
Kamal H, Sadr-Azodi O, Engstrand L, Brusselaers N. Association Between Proton Pump Inhibitor Use and Biliary Tract Cancer Risk: A Swedish Population-Based Cohort Study. Hepatology. 2021 Oct;74(4):2021-2031. doi: 10.1002/hep.31914. Epub 2021 Jul 13. PMID: 34018229.
Copy Download .nbib Format: NLM
Private sector engagement and contributions to immunisation service delivery and coverage in Sudan.

BMJ global health

Ahmed N, DeRoeck D, Sadr-Azodi N.
PMID: 31139460
BMJ Glob Health. 2019 Apr 16;4(2):e001414. doi: 10.1136/bmjgh-2019-001414. eCollection 2019.

For more than two decades, the private sector in the Sudan (henceforth, Sudan), including non-governmental organisations and for-profit providers, has played a key role in delivering immunisation services, especially in the conflict-affected Darfur region and the most populated Khartoum...

Cite
Ahmed N, DeRoeck D, Sadr-Azodi N. Private sector engagement and contributions to immunisation service delivery and coverage in Sudan. BMJ Glob Health. 2019;4(2):e001414doi: 10.1136/bmjgh-2019-001414.
Ahmed, N., DeRoeck, D., & Sadr-Azodi, N. (2019). Private sector engagement and contributions to immunisation service delivery and coverage in Sudan. BMJ global health, 4(2), e001414. https://doi.org/10.1136/bmjgh-2019-001414
Ahmed, Nada, et al. "Private sector engagement and contributions to immunisation service delivery and coverage in Sudan." BMJ global health vol. 4,2 (2019): e001414. doi: https://doi.org/10.1136/bmjgh-2019-001414
Ahmed N, DeRoeck D, Sadr-Azodi N. Private sector engagement and contributions to immunisation service delivery and coverage in Sudan. BMJ Glob Health. 2019 Apr 16;4(2):e001414. doi: 10.1136/bmjgh-2019-001414. eCollection 2019. PMID: 31139460; PMCID: PMC6509592.
Copy Download .nbib Format: NLM
A tug-of-war in intraductal papillary mucinous neoplasms management: Comparison between 2017 International and 2018 European guidelines.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Crippa S, Fogliati A, Valente R, Sadr-Azodi O, Arnelo U, Capurso G, Halimi A, Partelli S, Ateeb Z, Arcidiacono PG, Lohr JM, Falconi M, Del Chiaro M.
PMID: 33846103
Dig Liver Dis. 2021 Aug;53(8):998-1003. doi: 10.1016/j.dld.2021.03.009. Epub 2021 Apr 10.

BACKGROUND: 2017 International and 2018 European guidelines are the most recent guidelines for intraductal papillary mucinous neoplasms management.AIM: to evaluate the diagnostic accuracy of these guidelines in identifying malignant IPMN.METHODS: data from resected patients with IPMN were collected in...

Cite
Crippa S, Fogliati A, Valente R, et al. A tug-of-war in intraductal papillary mucinous neoplasms management: Comparison between 2017 International and 2018 European guidelines. Dig Liver Dis. 2021;53(8):998-1003doi: 10.1016/j.dld.2021.03.009.
Crippa, S., Fogliati, A., Valente, R., Sadr-Azodi, O., Arnelo, U., Capurso, G., Halimi, A., Partelli, S., Ateeb, Z., Arcidiacono, P. G., Lohr, J. M., Falconi, M., & Del Chiaro, M. (2021). A tug-of-war in intraductal papillary mucinous neoplasms management: Comparison between 2017 International and 2018 European guidelines. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 53(8), 998-1003. https://doi.org/10.1016/j.dld.2021.03.009
Crippa, Stefano, et al. "A tug-of-war in intraductal papillary mucinous neoplasms management: Comparison between 2017 International and 2018 European guidelines." Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver vol. 53,8 (2021): 998-1003. doi: https://doi.org/10.1016/j.dld.2021.03.009
Crippa S, Fogliati A, Valente R, Sadr-Azodi O, Arnelo U, Capurso G, Halimi A, Partelli S, Ateeb Z, Arcidiacono PG, Lohr JM, Falconi M, Del Chiaro M. A tug-of-war in intraductal papillary mucinous neoplasms management: Comparison between 2017 International and 2018 European guidelines. Dig Liver Dis. 2021 Aug;53(8):998-1003. doi: 10.1016/j.dld.2021.03.009. Epub 2021 Apr 10. PMID: 33846103.
Copy Download .nbib Format: NLM
Showing 1 to 10 of 10 entries